H-group (homology)
7571.1 Formyltransferase
Ligands and drugs
1,174
Member domains
232
with ligand contacts (≤ 4 Å)
19.8% of members
222
with DrugDomain annotations
18.9% of members
175
with a DrugBank compound
14.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7571.1 belongs to X-group 7571 Formyltransferase, which binds 8.1 ligand superclasses per 20 proteins, broader than 59% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02236 | GAR | Glycinamide Ribonucleotide | 35 |
| DB03256 | FON | (6R)-Folinic acid | 30 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 11 |
| DB03546 | KEU | N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid | 10 |
| DB01992 | COA | Coenzyme A | 8 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 7 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 5 |
| DB00158 | FOL | Folic acid | 4 |
| DB02031 | THG | (6S)-5,6,7,8-tetrahydrofolic acid | 4 |
| DB02794 | 138 | (2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid | 4 |
| DB02857 | GMP | Guanosine | 3 |
| DB00116 | — | — | 2 |
| DB02540 | NHS | 10-formyl-5,8,10-trideazafolic acid | 2 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 2 |
| DB03685 | U5P | Uridine monophosphate | 2 |
| DB03751 | DAU | 2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose | 2 |
| DB04264 | NHR | (10R)-10-formyl-5,8,10-trideazafolic acid | 2 |
| DB11256 | THH | Levomefolic acid | 2 |
| DB00134 | MET | Methionine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| GAR | GLYCINAMIDE RIBONUCLEOTIDE | 36 |
| FON | N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid | 30 |
| NAmetal | SODIUM ION | 21 |
| CL | CHLORIDE ION | 18 |
| TYD | THYMIDINE-5'-DIPHOSPHATE | 13 |
| 0FX | dTDP-4-amino-4,6-dideoxyglucose | 12 |
| KEU | N-{4-[(1R)-4-[(2R,4R,5S)-2,4-DIAMINO-6-OXOHEXAHYDROPYRIMIDIN-5-YL]-1-(2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYL)BUTYL]BENZOYL}-D-GLUTAMIC ACID | 10 |
| 1YJ | N-[4-({[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 9 |
| T3F | (3R,4S,5R,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 9 |
| COA | COENZYME A | 8 |
| T3Q | [(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate | 8 |
| 1YA | N-{4-[{[(6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}(formyl)amino]benzoyl}-L-glutamic acid | 7 |
| FGD | N-(4-{[(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}benzene-1-carbonyl)-D-glutamic acid | 7 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 7 |
| KT5 | N-{4-4-(2,4-DIAMINO-6-OXO-1,6-DIHYDRO-PYRIMIDIN-5-YL)-1-(2,2,2-TRIFLUORO-1,1-DIHYDROXY-ETHYL)-BUT-2-YL-BENZOYL}-GAMMA-GLUTAMYL-GAMMA-GLUTAMYL-GAMMA-GLUTAMYL-GAMMA-GLUTAMYL-GLUTAMIC ACID | 6 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 6 |
| Kmetal | POTASSIUM ION | 5 |
| UNL | Unknown ligand | 5 |
| 138 | N-[5'-O-PHOSPHONO-RIBOFURANOSYL]-2-[2-HYDROXY-2-[4-[GLUTAMIC ACID]-N-CARBONYLPHENYL]-3-[2-AMINO-4-HYDROXY-QUINAZOLIN-6-YL]-PROPANYLAMINO]-ACETAMIDE | 4 |
| DZF | 5-DEAZAFOLIC ACID | 4 |